The global market for Valacyclovir Oral was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.

North American market for Valacyclovir Oral is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Valacyclovir Oral is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Valacyclovir Oral include GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals, Time Cap Labs, Wockhardt, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Valacyclovir Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir Oral.

The Valacyclovir Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Valacyclovir Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Valacyclovir Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Valacyclovir Oral Market Report

Report Metric	Details
Report Name	Valacyclovir Oral Market
Segment by Type	500mg Tablet 1000mg Tablet 300mg Tablet Others
Segment by Application	Hospital Drug Store
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals, Time Cap Labs, Wockhardt, Apotex, Aurobindo Pharma, Jubilant Pharma, Lunan Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Tasly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valacyclovir Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Valacyclovir Oral Market report?

Ans: The main players in the Valacyclovir Oral Market are GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals, Time Cap Labs, Wockhardt, Apotex, Aurobindo Pharma, Jubilant Pharma, Lunan Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Tasly

What are the Application segmentation covered in the Valacyclovir Oral Market report?

Ans: The Applications covered in the Valacyclovir Oral Market report are Hospital, Drug Store

What are the Type segmentation covered in the Valacyclovir Oral Market report?

Ans: The Types covered in the Valacyclovir Oral Market report are 500mg Tablet, 1000mg Tablet, 300mg Tablet, Others

1 Valacyclovir Oral Market Overview

1.1 Product Definition

1.2 Valacyclovir Oral by Type

1.2.1 Global Valacyclovir Oral Market Value Comparison by Type (2024 VS 2031)

1.2.2 500mg Tablet

1.2.3 1000mg Tablet

1.2.4 300mg Tablet

1.2.5 Others

1.3 Valacyclovir Oral by Application

1.3.1 Global Valacyclovir Oral Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Drug Store

1.4 Global Valacyclovir Oral Market Size Estimates and Forecasts

1.4.1 Global Valacyclovir Oral Revenue 2020-2031

1.4.2 Global Valacyclovir Oral Sales 2020-2031

1.4.3 Global Valacyclovir Oral Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Valacyclovir Oral Market Competition by Manufacturers

2.1 Global Valacyclovir Oral Sales Market Share by Manufacturers (2020-2025)

2.2 Global Valacyclovir Oral Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Valacyclovir Oral Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Valacyclovir Oral, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Valacyclovir Oral, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Valacyclovir Oral, Product Type & Application

2.7 Global Key Manufacturers of Valacyclovir Oral, Date of Enter into This Industry

2.8 Global Valacyclovir Oral Market Competitive Situation and Trends

2.8.1 Global Valacyclovir Oral Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Valacyclovir Oral Players Market Share by Revenue

2.8.3 Global Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Valacyclovir Oral Market Scenario by Region

3.1 Global Valacyclovir Oral Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Valacyclovir Oral Sales by Region: 2020-2031

3.2.1 Global Valacyclovir Oral Sales by Region: 2020-2025

3.2.2 Global Valacyclovir Oral Sales by Region: 2026-2031

3.3 Global Valacyclovir Oral Revenue by Region: 2020-2031

3.3.1 Global Valacyclovir Oral Revenue by Region: 2020-2025

3.3.2 Global Valacyclovir Oral Revenue by Region: 2026-2031

3.4 North America Valacyclovir Oral Market Facts & Figures by Country

3.4.1 North America Valacyclovir Oral Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Valacyclovir Oral Sales by Country (2020-2031)

3.4.3 North America Valacyclovir Oral Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Valacyclovir Oral Market Facts & Figures by Country

3.5.1 Europe Valacyclovir Oral Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Valacyclovir Oral Sales by Country (2020-2031)

3.5.3 Europe Valacyclovir Oral Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Valacyclovir Oral Market Facts & Figures by Region

3.6.1 Asia Pacific Valacyclovir Oral Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Valacyclovir Oral Sales by Region (2020-2031)

3.6.3 Asia Pacific Valacyclovir Oral Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Valacyclovir Oral Market Facts & Figures by Country

3.7.1 Latin America Valacyclovir Oral Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Valacyclovir Oral Sales by Country (2020-2031)

3.7.3 Latin America Valacyclovir Oral Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Valacyclovir Oral Market Facts & Figures by Country

3.8.1 Middle East and Africa Valacyclovir Oral Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Valacyclovir Oral Sales by Country (2020-2031)

3.8.3 Middle East and Africa Valacyclovir Oral Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Valacyclovir Oral Sales by Type (2020-2031)

4.1.1 Global Valacyclovir Oral Sales by Type (2020-2025)

4.1.2 Global Valacyclovir Oral Sales by Type (2026-2031)

4.1.3 Global Valacyclovir Oral Sales Market Share by Type (2020-2031)

4.2 Global Valacyclovir Oral Revenue by Type (2020-2031)

4.2.1 Global Valacyclovir Oral Revenue by Type (2020-2025)

4.2.2 Global Valacyclovir Oral Revenue by Type (2026-2031)

4.2.3 Global Valacyclovir Oral Revenue Market Share by Type (2020-2031)

4.3 Global Valacyclovir Oral Price by Type (2020-2031)

5 Segment by Application

5.1 Global Valacyclovir Oral Sales by Application (2020-2031)

5.1.1 Global Valacyclovir Oral Sales by Application (2020-2025)

5.1.2 Global Valacyclovir Oral Sales by Application (2026-2031)

5.1.3 Global Valacyclovir Oral Sales Market Share by Application (2020-2031)

5.2 Global Valacyclovir Oral Revenue by Application (2020-2031)

5.2.1 Global Valacyclovir Oral Revenue by Application (2020-2025)

5.2.2 Global Valacyclovir Oral Revenue by Application (2026-2031)

5.2.3 Global Valacyclovir Oral Revenue Market Share by Application (2020-2031)

5.3 Global Valacyclovir Oral Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Company Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GSK Valacyclovir Oral Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Sandoz

6.2.1 Sandoz Company Information

6.2.2 Sandoz Description and Business Overview

6.2.3 Sandoz Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sandoz Valacyclovir Oral Product Portfolio

6.2.5 Sandoz Recent Developments/Updates

6.3 Sun Pharmaceutical

6.3.1 Sun Pharmaceutical Company Information

6.3.2 Sun Pharmaceutical Description and Business Overview

6.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sun Pharmaceutical Valacyclovir Oral Product Portfolio

6.3.5 Sun Pharmaceutical Recent Developments/Updates

6.4 Cipla

6.4.1 Cipla Company Information

6.4.2 Cipla Description and Business Overview

6.4.3 Cipla Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cipla Valacyclovir Oral Product Portfolio

6.4.5 Cipla Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Company Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Valacyclovir Oral Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Teva

6.6.1 Teva Company Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Teva Valacyclovir Oral Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Zydus Pharmaceuticals

6.7.1 Zydus Pharmaceuticals Company Information

6.7.2 Zydus Pharmaceuticals Description and Business Overview

6.7.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio

6.7.5 Zydus Pharmaceuticals Recent Developments/Updates

6.8 West-Ward Pharmaceuticals

6.8.1 West-Ward Pharmaceuticals Company Information

6.8.2 West-Ward Pharmaceuticals Description and Business Overview

6.8.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.8.4 West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio

6.8.5 West-Ward Pharmaceuticals Recent Developments/Updates

6.9 Time Cap Labs

6.9.1 Time Cap Labs Company Information

6.9.2 Time Cap Labs Description and Business Overview

6.9.3 Time Cap Labs Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Time Cap Labs Valacyclovir Oral Product Portfolio

6.9.5 Time Cap Labs Recent Developments/Updates

6.10 Wockhardt

6.10.1 Wockhardt Company Information

6.10.2 Wockhardt Description and Business Overview

6.10.3 Wockhardt Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Wockhardt Valacyclovir Oral Product Portfolio

6.10.5 Wockhardt Recent Developments/Updates

6.11 Apotex

6.11.1 Apotex Company Information

6.11.2 Apotex Description and Business Overview

6.11.3 Apotex Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Apotex Valacyclovir Oral Product Portfolio

6.11.5 Apotex Recent Developments/Updates

6.12 Aurobindo Pharma

6.12.1 Aurobindo Pharma Company Information

6.12.2 Aurobindo Pharma Description and Business Overview

6.12.3 Aurobindo Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Aurobindo Pharma Valacyclovir Oral Product Portfolio

6.12.5 Aurobindo Pharma Recent Developments/Updates

6.13 Jubilant Pharma

6.13.1 Jubilant Pharma Company Information

6.13.2 Jubilant Pharma Description and Business Overview

6.13.3 Jubilant Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Jubilant Pharma Valacyclovir Oral Product Portfolio

6.13.5 Jubilant Pharma Recent Developments/Updates

6.14 Lunan Pharmaceutical

6.14.1 Lunan Pharmaceutical Company Information

6.14.2 Lunan Pharmaceutical Description and Business Overview

6.14.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Lunan Pharmaceutical Valacyclovir Oral Product Portfolio

6.14.5 Lunan Pharmaceutical Recent Developments/Updates

6.15 Shandong Luoxin Pharmaceutical Group

6.15.1 Shandong Luoxin Pharmaceutical Group Company Information

6.15.2 Shandong Luoxin Pharmaceutical Group Description and Business Overview

6.15.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio

6.15.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates

6.16 Tasly

6.16.1 Tasly Company Information

6.16.2 Tasly Description and Business Overview

6.16.3 Tasly Valacyclovir Oral Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Tasly Valacyclovir Oral Product Portfolio

6.16.5 Tasly Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Valacyclovir Oral Industry Chain Analysis

7.2 Valacyclovir Oral Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Valacyclovir Oral Production Mode & Process Analysis

7.4 Valacyclovir Oral Sales and Marketing

7.4.1 Valacyclovir Oral Sales Channels

7.4.2 Valacyclovir Oral Distributors

7.5 Valacyclovir Oral Customer Analysis

8 Valacyclovir Oral Market Dynamics

8.1 Valacyclovir Oral Industry Trends

8.2 Valacyclovir Oral Market Drivers

8.3 Valacyclovir Oral Market Challenges

8.4 Valacyclovir Oral Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Zydus Pharmaceuticals

West Ward Pharmaceuticals

Shandong Luoxin Pharmaceutical Group

TASLY

List of Tables

Table 1. Global Valacyclovir Oral Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Valacyclovir Oral Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Valacyclovir Oral Market Competitive Situation by Manufacturers in 2024

Table 4. Global Valacyclovir Oral Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Valacyclovir Oral Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Valacyclovir Oral Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Valacyclovir Oral Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Valacyclovir Oral Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Valacyclovir Oral, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Valacyclovir Oral, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Valacyclovir Oral, Product Type & Application

Table 12. Global Key Manufacturers of Valacyclovir Oral, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Valacyclovir Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valacyclovir Oral as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Valacyclovir Oral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Valacyclovir Oral Sales by Region (2020-2025) & (K Units)

Table 18. Global Valacyclovir Oral Sales Market Share by Region (2020-2025)

Table 19. Global Valacyclovir Oral Sales by Region (2026-2031) & (K Units)

Table 20. Global Valacyclovir Oral Sales Market Share by Region (2026-2031)

Table 21. Global Valacyclovir Oral Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Valacyclovir Oral Revenue Market Share by Region (2020-2025)

Table 23. Global Valacyclovir Oral Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Valacyclovir Oral Revenue Market Share by Region (2026-2031)

Table 25. North America Valacyclovir Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Valacyclovir Oral Sales by Country (2020-2025) & (K Units)

Table 27. North America Valacyclovir Oral Sales by Country (2026-2031) & (K Units)

Table 28. North America Valacyclovir Oral Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Valacyclovir Oral Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Valacyclovir Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Valacyclovir Oral Sales by Country (2020-2025) & (K Units)

Table 32. Europe Valacyclovir Oral Sales by Country (2026-2031) & (K Units)

Table 33. Europe Valacyclovir Oral Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Valacyclovir Oral Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Valacyclovir Oral Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Valacyclovir Oral Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Valacyclovir Oral Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Valacyclovir Oral Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Valacyclovir Oral Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Valacyclovir Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Valacyclovir Oral Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Valacyclovir Oral Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Valacyclovir Oral Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Valacyclovir Oral Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Valacyclovir Oral Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Valacyclovir Oral Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Valacyclovir Oral Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Valacyclovir Oral Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Valacyclovir Oral Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Valacyclovir Oral Sales (K Units) by Type (2020-2025)

Table 51. Global Valacyclovir Oral Sales (K Units) by Type (2026-2031)

Table 52. Global Valacyclovir Oral Sales Market Share by Type (2020-2025)

Table 53. Global Valacyclovir Oral Sales Market Share by Type (2026-2031)

Table 54. Global Valacyclovir Oral Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Valacyclovir Oral Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Valacyclovir Oral Revenue Market Share by Type (2020-2025)

Table 57. Global Valacyclovir Oral Revenue Market Share by Type (2026-2031)

Table 58. Global Valacyclovir Oral Price (USD/Unit) by Type (2020-2025)

Table 59. Global Valacyclovir Oral Price (USD/Unit) by Type (2026-2031)

Table 60. Global Valacyclovir Oral Sales (K Units) by Application (2020-2025)

Table 61. Global Valacyclovir Oral Sales (K Units) by Application (2026-2031)

Table 62. Global Valacyclovir Oral Sales Market Share by Application (2020-2025)

Table 63. Global Valacyclovir Oral Sales Market Share by Application (2026-2031)

Table 64. Global Valacyclovir Oral Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Valacyclovir Oral Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Valacyclovir Oral Revenue Market Share by Application (2020-2025)

Table 67. Global Valacyclovir Oral Revenue Market Share by Application (2026-2031)

Table 68. Global Valacyclovir Oral Price (USD/Unit) by Application (2020-2025)

Table 69. Global Valacyclovir Oral Price (USD/Unit) by Application (2026-2031)

Table 70. GSK Company Information

Table 71. GSK Description and Business Overview

Table 72. GSK Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. GSK Valacyclovir Oral Product

Table 74. GSK Recent Developments/Updates

Table 75. Sandoz Company Information

Table 76. Sandoz Description and Business Overview

Table 77. Sandoz Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Sandoz Valacyclovir Oral Product

Table 79. Sandoz Recent Developments/Updates

Table 80. Sun Pharmaceutical Company Information

Table 81. Sun Pharmaceutical Description and Business Overview

Table 82. Sun Pharmaceutical Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Sun Pharmaceutical Valacyclovir Oral Product

Table 84. Sun Pharmaceutical Recent Developments/Updates

Table 85. Cipla Company Information

Table 86. Cipla Description and Business Overview

Table 87. Cipla Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Cipla Valacyclovir Oral Product

Table 89. Cipla Recent Developments/Updates

Table 90. Mylan Company Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Valacyclovir Oral Product

Table 94. Mylan Recent Developments/Updates

Table 95. Teva Company Information

Table 96. Teva Description and Business Overview

Table 97. Teva Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Teva Valacyclovir Oral Product

Table 99. Teva Recent Developments/Updates

Table 100. Zydus Pharmaceuticals Company Information

Table 101. Zydus Pharmaceuticals Description and Business Overview

Table 102. Zydus Pharmaceuticals Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Zydus Pharmaceuticals Valacyclovir Oral Product

Table 104. Zydus Pharmaceuticals Recent Developments/Updates

Table 105. West-Ward Pharmaceuticals Company Information

Table 106. West-Ward Pharmaceuticals Description and Business Overview

Table 107. West-Ward Pharmaceuticals Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. West-Ward Pharmaceuticals Valacyclovir Oral Product

Table 109. West-Ward Pharmaceuticals Recent Developments/Updates

Table 110. Time Cap Labs Company Information

Table 111. Time Cap Labs Description and Business Overview

Table 112. Time Cap Labs Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Time Cap Labs Valacyclovir Oral Product

Table 114. Time Cap Labs Recent Developments/Updates

Table 115. Wockhardt Company Information

Table 116. Wockhardt Description and Business Overview

Table 117. Wockhardt Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Wockhardt Valacyclovir Oral Product

Table 119. Wockhardt Recent Developments/Updates

Table 120. Apotex Company Information

Table 121. Apotex Description and Business Overview

Table 122. Apotex Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Apotex Valacyclovir Oral Product

Table 124. Apotex Recent Developments/Updates

Table 125. Aurobindo Pharma Company Information

Table 126. Aurobindo Pharma Description and Business Overview

Table 127. Aurobindo Pharma Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Aurobindo Pharma Valacyclovir Oral Product

Table 129. Aurobindo Pharma Recent Developments/Updates

Table 130. Jubilant Pharma Company Information

Table 131. Jubilant Pharma Description and Business Overview

Table 132. Jubilant Pharma Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Jubilant Pharma Valacyclovir Oral Product

Table 134. Jubilant Pharma Recent Developments/Updates

Table 135. Lunan Pharmaceutical Company Information

Table 136. Lunan Pharmaceutical Description and Business Overview

Table 137. Lunan Pharmaceutical Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Lunan Pharmaceutical Valacyclovir Oral Product

Table 139. Lunan Pharmaceutical Recent Developments/Updates

Table 140. Shandong Luoxin Pharmaceutical Group Company Information

Table 141. Shandong Luoxin Pharmaceutical Group Description and Business Overview

Table 142. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product

Table 144. Shandong Luoxin Pharmaceutical Group Recent Developments/Updates

Table 145. Tasly Company Information

Table 146. Tasly Description and Business Overview

Table 147. Tasly Valacyclovir Oral Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Tasly Valacyclovir Oral Product

Table 149. Tasly Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Valacyclovir Oral Distributors List

Table 153. Valacyclovir Oral Customers List

Table 154. Valacyclovir Oral Market Trends

Table 155. Valacyclovir Oral Market Drivers

Table 156. Valacyclovir Oral Market Challenges

Table 157. Valacyclovir Oral Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Valacyclovir Oral

Figure 2. Global Valacyclovir Oral Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Valacyclovir Oral Market Share by Type: 2024 & 2031

Figure 4. 500mg Tablet Product Picture

Figure 5. 1000mg Tablet Product Picture

Figure 6. 300mg Tablet Product Picture

Figure 7. Others Product Picture

Figure 8. Global Valacyclovir Oral Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Valacyclovir Oral Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Drug Store

Figure 12. Global Valacyclovir Oral Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Valacyclovir Oral Market Size (2020-2031) & (US$ Million)

Figure 14. Global Valacyclovir Oral Sales (2020-2031) & (K Units)

Figure 15. Global Valacyclovir Oral Average Price (USD/Unit) & (2020-2031)

Figure 16. Valacyclovir Oral Report Years Considered

Figure 17. Valacyclovir Oral Sales Share by Manufacturers in 2024

Figure 18. Global Valacyclovir Oral Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Valacyclovir Oral Players: Market Share by Revenue in Valacyclovir Oral in 2024

Figure 20. Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Valacyclovir Oral Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Valacyclovir Oral Sales Market Share by Country (2020-2031)

Figure 23. North America Valacyclovir Oral Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Valacyclovir Oral Sales Market Share by Country (2020-2031)

Figure 27. Europe Valacyclovir Oral Revenue Market Share by Country (2020-2031)

Figure 28. Germany Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Valacyclovir Oral Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Valacyclovir Oral Revenue Market Share by Region (2020-2031)

Figure 35. China Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Valacyclovir Oral Sales Market Share by Country (2020-2031)

Figure 46. Latin America Valacyclovir Oral Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Valacyclovir Oral Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Valacyclovir Oral Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Valacyclovir Oral Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Valacyclovir Oral by Type (2020-2031)

Figure 56. Global Revenue Market Share of Valacyclovir Oral by Type (2020-2031)

Figure 57. Global Valacyclovir Oral Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Valacyclovir Oral by Application (2020-2031)

Figure 59. Global Revenue Market Share of Valacyclovir Oral by Application (2020-2031)

Figure 60. Global Valacyclovir Oral Price (USD/Unit) by Application (2020-2031)

Figure 61. Valacyclovir Oral Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions